TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | ||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | SUMMIT THERAPEUTICS PLC | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | x | |||
Other (please specify): | ||||
3. Full name of person(s) subject to the notification obligation: iii | Polar Capital LLP | |||
4. Full name of shareholder(s) (if different from 3.):iv | ||||
5. Date of the transaction and date on which the threshold is crossed or reached: v | 10.03.2015 | |||
6. Date on which issuer notified: | 12.03.2015 | |||
7. Threshold(s) that is/are crossed or reached: vi, vii | <3% |
8. Notified details: | ||||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||||
Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||||
GB00BN40HZ01 | 1,303,066 | 1,303,066 | 1,303,066 | 1,303,066 | 2.23% | |||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||||
Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||||
N/A | ||||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||||
Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||||
N/A | | Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||||
1,303,066 | 2.23% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will cease to hold: | ||
12. Date on which proxy holder will cease to hold voting rights: | ||
13. Additional information: | | |
14. Contact name: | Polar Capital Operations Department | |
15. Contact telephone number: | +44 (0) 207 227 2700 |